Sexually transmitted infection

Global Sexually Transmitted Diseases (STDs) Drug Market Research Report 2021-2027 - ResearchAndMarkets.com

Friday, June 11, 2021 - 1:28pm

The "Sexually Transmitted Diseases (STDs) Drug - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Sexually Transmitted Diseases (STDs) Drug - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • Amid the COVID-19 crisis, the global market for Sexually Transmitted Diseases (STDs) Drug estimated at US$47.7 Billion in the year 2020, is projected to reach a revised size of US$91.7 Billion by 2027, growing at a CAGR of 9.8% over the analysis period 2020-2027.
  • Chlamydia, one of the segments analyzed in the report, is projected to record a 10% CAGR and reach US$14.4 Billion by the end of the analysis period.
  • The U.S. Market is Estimated at $12.9 Billion, While China is Forecast to Grow at 13.1% CAGR
    The Sexually Transmitted Diseases (STDs) Drug market in the U.S. is estimated at US$12.9 Billion in the year 2020.

Evofem Biosciences to Present at Jefferies Virtual Healthcare Conference 2021

Tuesday, June 1, 2021 - 2:00pm

Evofem Biosciences, Inc., (NASDAQ:EVFM) is developing and commercializing innovativeproducts to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs).

Key Points: 
  • Evofem Biosciences, Inc., (NASDAQ:EVFM) is developing and commercializing innovativeproducts to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs).
  • The Company launched its first FDA-approved commercial product, Phexxi (lactic acid, citric acid and potassium bitartrate), inthe United StatesinSeptember 2020.
  • The Company is evaluating lead product candidate EVO100 for the prevention of urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infection in women in the ongoing Phase 3 clinical trial, 'EVOGUARD .'
  • Phexxiis a registered trademark of Evofem Biosciences, Inc.

$17.1 Billion Worldwide Condom Industry to 2027 - Featuring Mayer Laboratories, Okamoto Industries and Cupid Limited Among Others - ResearchAndMarkets.com

Tuesday, June 1, 2021 - 12:20pm

The Global Condom Market size is expected to reach $17.1 billion by 2027, rising at a market growth of 9.5% CAGR during the forecast period.

Key Points: 
  • The Global Condom Market size is expected to reach $17.1 billion by 2027, rising at a market growth of 9.5% CAGR during the forecast period.
  • By using condoms, the risks of various sexually transmitted diseases (STDs) can be reduced to a great extent.
  • Thus, the two major catalysts for the demand & growth of condoms are contraception and the prevention of STDs.
  • In addition to it, the market is mainly driven by male-based products, but female-based products have started gaining traction in recent years.

Quest Diagnostics Expands Eligibility for $0 Out-of-Pocket COVID-19 Testing Through QuestDirect™ To Assist in Combatting the Pandemic and Help Support Safer Travel, Events and Gatherings Nationwide

Tuesday, May 11, 2021 - 2:05pm

"As more people are vaccinated and the economy opens, greater flexibility and affordability in COVID-19 testing will help keep us all safer.

Key Points: 
  • "As more people are vaccinated and the economy opens, greater flexibility and affordability in COVID-19 testing will help keep us all safer.
  • We believe this option for COVID-19 testing will enable individuals and families to return to normal activities more safely and responsibly.
  • Our QuestDirect consumer-initiated test platform provides dozens of tests for conditions ranging from heart health to sexually transmitted diseases.
  • We were among the first diagnostic information services providers to offer free access to test results online and other channels.

Insights on the Sexually Transmitted Disease (STD) Testing Global Market to 2025 - The Presence of Favorable Reimbursement Policies is Driving Growth - ResearchAndMarkets.com

Friday, May 7, 2021 - 2:48pm

b'The "Global Sexually Transmitted Disease (STD) Testing Market 2021-2025" report has been added to ResearchAndMarkets.com\'s offering.\nThe publisher has been monitoring the sexually transmitted disease (STD) testing market and it is poised to grow by $74.64 million during 2021-2025, progressing at a CAGR of over 8% during the forecast period.\nThe report on sexually transmitted disease (STD) testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.\nThe report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment.

Key Points: 
  • b'The "Global Sexually Transmitted Disease (STD) Testing Market 2021-2025" report has been added to ResearchAndMarkets.com\'s offering.\nThe publisher has been monitoring the sexually transmitted disease (STD) testing market and it is poised to grow by $74.64 million during 2021-2025, progressing at a CAGR of over 8% during the forecast period.\nThe report on sexually transmitted disease (STD) testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.\nThe report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment.
  • The market is driven by the increased initiatives by governments worldwide, the presence of favorable reimbursement policies, and the increasing prevalence of STDs.\nThe sexually transmitted disease (STD) testing market analysis includes product segment and geographic landscape.
  • This study identifies the increasing involvement of various organizations to create awareness about STDs as one of the prime reasons driving the sexually transmitted disease (STD) testing market growth during the next few years.
  • Also, advances that enable the rapid diagnosis of STDs and approval of drugs and strong drug pipeline will lead to sizable demand in the market.\n'

Global Human Papillomavirus Infections Epidemiology and Patient Flow Research Report 2021 - ResearchAndMarkets.com

Friday, May 7, 2021 - 2:28pm

b'The "Global Human Papillomavirus Infections Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nGlobal Human Papillomavirus Infections Epidemiology and Patient Flow Analysis - 2021, provides Human Papillomavirus Infections epidemiology, demographics, and patient flow.

Key Points: 
  • b'The "Global Human Papillomavirus Infections Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nGlobal Human Papillomavirus Infections Epidemiology and Patient Flow Analysis - 2021, provides Human Papillomavirus Infections epidemiology, demographics, and patient flow.
  • The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.\nThe research provides population data to characterize Human Papillomavirus Infections patients, history of the disease at the population level (Human Papillomavirus Infections prevalence, Human Papillomavirus Infections incidence) and at the clinical level (from diagnosis to treated patients).
  • It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.\nHuman Papillomavirus Infections patient flow: Human Papillomavirus Infections prevalence, diagnosed, and drug-treated patients\nDemographics: Human Papillomavirus Infections patients by age group, gender\nThe data from this research will help executives:\nEstablish basis for Human Papillomavirus Infections market sizing, assessing market potential, and developing drug forecast models\nIdentify Human Papillomavirus Infections patients segments through age groups, gender, and disease sub-types\nEvaluate Human Papillomavirus Infections market opportunities, identify target patient population\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210507005368/en/\n'

Sexually Transmitted Disease (STD) Testing Market to Grow by USD 74.64 Million During 2021-2025|Technavio

Wednesday, April 28, 2021 - 12:00am

b"The sexually transmitted disease (STD) testing market is expected to grow by USD74.64 million during 2021-2025, according to Technavio.

Key Points: 
  • b"The sexually transmitted disease (STD) testing market is expected to grow by USD74.64 million during 2021-2025, according to Technavio.
  • The report offers a detailed analysis of the impact of the COVID-19 pandemic on the sexually transmitted disease (STD) testing market in optimistic, probable, and pessimistic forecast scenarios.\nEnterprises will go through the Response, Recovery, and Renew phases.\nThe sexually transmitted disease (STD) testing market will witness a neutral impact during the forecast period, owing to the widespread growth of the COVID-19 pandemic.
  • As per Technavio's pandemic-focused market research, market growth is likely to increase in 2021 as compared to 2020.\nWith the continuing spread of the novel coronavirus pandemic, organizations across the globe are gradually flattening their recessionary curve by leveraging technology.
  • Get a report snapshot here to get a detailed market share analysis of market participants during COVID-19 lockdown:\nSexually Transmitted Disease (STD) Testing Market 2021-2025: Segmentation\nThe sexually transmitted disease (STD) testing market is segmented as below:\n"

binx health Announces First At-Home Collection Kits for Sexually Transmitted Infections Available Through Walgreens Find Care

Tuesday, April 27, 2021 - 1:00pm

b'BOSTON, April 27, 2021 /PRNewswire/ --binx health today announced that the Company\'s at-home sample collection kits for sexually transmitted infections (STIs) are now available through Walgreens Find Care , a digital health platform found on the Walgreens app and at Walgreens.com.

Key Points: 
  • b'BOSTON, April 27, 2021 /PRNewswire/ --binx health today announced that the Company\'s at-home sample collection kits for sexually transmitted infections (STIs) are now available through Walgreens Find Care , a digital health platform found on the Walgreens app and at Walgreens.com.
  • Due to the convenience of at-home sample collection, consumers can potentially shorten illness times, prevent transmission and improve sexual health.
  • "\nSexually transmitted infections have been on the rise for years, but the COVID-19 pandemic has greatly affected access to in-person STI testing, treatment, and preventative care.
  • "The collaboration between binx health and Walgreens reflects both companies\' commitment to making quality, consumer-centered care convenient and accessible, helping our communities protect their health and well-being.

Should Women in Their 40s, 50s, Still See the Gynecologist?

Thursday, March 25, 2021 - 12:38pm

For women in their 20s and 30s gynecologists are concerned about sexually transmitted diseases and fertility, but as women age, other female medical issues become a priority.

Key Points: 
  • For women in their 20s and 30s gynecologists are concerned about sexually transmitted diseases and fertility, but as women age, other female medical issues become a priority.
  • "Women in their 40s and 50s should have an annual pap smear and breast exam to assure good health and screen for cancer," said Dr. Webb.
  • Low energy, leaking bladder issues and low libido often change a woman's life in this age range.
  • Women in their 40s, may notice heavier periods or period problems that could be an indication of medical problems like endometriosis.

Testing.com Announces Best Free STD Testing Organizations in Columbus, OH

Friday, March 12, 2021 - 5:00am

SEATTLE, March 12, 2021 /PRNewswire-PRWeb/ -- Testing.com , a trusted informational guide for medical lab testing and at-home screening, has published a report on the increasing STD cases and resources for addressing this issue in Columbus, including top local organizations with free or low-cost health screening options for residents.

Key Points: 
  • SEATTLE, March 12, 2021 /PRNewswire-PRWeb/ -- Testing.com , a trusted informational guide for medical lab testing and at-home screening, has published a report on the increasing STD cases and resources for addressing this issue in Columbus, including top local organizations with free or low-cost health screening options for residents.
  • According to the Chlamydia Five Year Report published by the Ohio Department of Health, the number of reported chlamydia cases in Franklin County increased from 8,088 to 10,179 between 2014 and 2018 while Ohio's Gonorrhea Five Year Report shows a drastic increase in the number of reported cases of gonorrhea statewide between 2014 and 2018.
  • The Total Syphilis Five Year Report states that while the number of reported syphilis cases in Columbus declined by 25% between 2016 and 2017, the city still leads the state in the number of reported cases.
  • The report features the following organizations: